OSCR الفئة A Oscar Health, Inc. Class A Common Stock
NYSE · Insurance · عرض على SEC EDGAR ↗ إغلاق أكتوبر 2, 2026 10-K/10-Q أغسطس 7, 2026OSCR لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
OSCR مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
تتكيف دقة الشريط مع الفترة المحددة - مرر مؤشر الفأرة فوق الرسم البياني لرؤية الافتتاح/الأعلى/الأدنى/الإغلاق للشريط.
حول Oscar Health, Inc. Class A Common Stock نظرة عامة على الشركة من ويكيبيديا
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
History
2012–2015
According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.
2016
Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".
In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."
2017
On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.
On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.
A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.
While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.
2020–present
In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."
As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."
Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.
Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.
Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.
In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.
Marketing and brand
Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".
In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.
In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.
Finances
Funding
Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.
During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.
During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.
In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.
During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.
In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.
Revenue
In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.
Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."
By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.
In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.
In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.
In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.
In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.
Headquarters and offices
Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
| المقياس | اتجاه 5 سنوات | OSCR | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| P/E (سنوي حالي) | 21.3متوسط 5 سنوات ≈23.0 | ≈23.0 | 15.4 | مبالغ في تقييمه |
يتم حساب الوسيط النظير على أساس موحد لكل مقياس وقد لا يتطابق دائمًا مع الأساس السنوي الحالي/الربع الأخير المعروض لهذا السهم.
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
| المقياس | اتجاه 5 سنوات | OSCR | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| هامش التشغيل (سنوي حالي) | 4.1%متوسط 5 سنوات ≈-9.1% | ≈-9.1% | 10.1% | ضعيف | |
| هامش EBITDA (سنوي حالي) | 4.3%متوسط 5 سنوات ≈-8.6% | ≈-8.6% | 8.2% | متوافق | |
| هامش ما قبل الضريبة (سنوي حالي) | 3.9%متوسط 5 سنوات ≈-9.7% | ≈-9.7% | 17.3% | ضعيف | |
| هامش صافي الربح (سنوي حالي) | 3.6%متوسط 5 سنوات ≈-9.8% | ≈-9.8% | 10.3% | ضعيف | |
| العائد على الأصول (سنوي حالي) | 6.3%متوسط 5 سنوات ≈-8.6% | ≈-8.6% | 0.54% | ضعيف | |
| ROE (سنوي حالي) | 34.3%متوسط 5 سنوات ≈-27.6% | ≈-27.6% | 12.2% | ضعيف | |
| ROIC | -28.5%متوسط 5 سنوات ≈-21.5% | ≈-21.5% | 15.6% | ضعيف |
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
| المقياس | اتجاه 5 سنوات | OSCR | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| الدين / حقوق الملكية (الربع الأخير) | 0.2متوسط 5 سنوات ≈0.3 | ≈0.3 | 0.0 | ديون مرتفعة | |
| النسبة الحالية (الربع الأخير) | 1.1متوسط 5 سنوات ≈1.1 | ≈1.1 | · | · | |
| Quick Ratio (النسبة السريعة) | 0.6متوسط 5 سنوات ≈0.6 | ≈0.6 | · | · | |
| الدين طويل الأجل / حقوق الملكية (الربع الأخير) | 0.2متوسط 5 سنوات ≈0.3 | ≈0.3 | · | · |
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
| المقياس | اتجاه 5 سنوات | OSCR | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Revenue YoY (الإيرادات مقارنة بالعام السابق) | 27.5%متوسط 5 سنوات ≈109.0% | ≈109.0% | · | · | |
| Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات) | 43.5%متوسط 5 سنوات ≈82.5% | ≈82.5% | · | · | |
| Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات) | 90.8% | · | · | · |
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
| المقياس | اتجاه 5 سنوات | OSCR | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Asset Turnover (دوران الأصول) | 2.1متوسط 5 سنوات ≈1.6 | ≈1.6 | 0.1 | من الدرجة الأولى | |
| Revenue / Employee (الإيرادات / الموظف) | ≈$5.1M | · | · | · |
القيمة · ≈ متوسط 5 سنوات · متوسط الصناعة · حكم مقارنة بالمتوسط
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | تقرير | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|---|
| 30 يونيو، 2026 | أغسطس 6, 2026 | $1.10 | $0.39 | 179.5% |
| 31 مارس، 2026 | $2.07 | $1.21 | 71.5% | |
| 31 ديسمبر، 2025 | $-1.24 | $-0.91 | -37.0% | |
| 30 سبتمبر، 2025 | $-0.53 | $-0.57 | 6.6% | |
| 30 يونيو، 2025 | $-0.89 | $-0.47 | -88.5% | |
| 31 مارس، 2025 | $0.92 | $0.81 | 13.8% |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $463M | |
| SG&A Expense | $2.05B | $1.76B | $1.43B | $1.26B | $265M | $167M | |
| Operating Income | $-396M | $57M | $-236M | $-590M | $-544M | $-402M | |
| Interest Expense | · | · | $25M | $23M | $5M | $4M | |
| Other Non-op | $-23M | $-105.0K | $-7M | $2M | $-1M | · | |
| Pretax Income | $-437M | $33M | $-267M | $-610M | $-571M | $-406M | |
| Income Tax | $6M | $7M | $3M | $-523.0K | $846.0K | $1M | |
| Net Income | $-443M | $25M | $-271M | $-606M | $-573M | $-407M | |
| EPS (Basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| Shares (Basic) | 262,388,000 | 240,386,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| Shares (Diluted) | 262,388,000 | 265,853,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| EBITDA | $-367M | $89M | $-205M | · | $-530M | · |
الميزانية العمومية
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826M | |
| Short-term Investments | · | $624M | $690M | · | · | · | |
| Receivables | $363M | · | · | · | · | · | |
| Other Current Assets | $24M | $21M | $7M | $6M | $4M | · | |
| Current Assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | |
| PP&E (Net) | $88M | $67M | $62M | $60M | $47M | $36M | |
| PP&E (Gross) | $230M | $181M | $150M | $117M | $89M | $63M | |
| Accum. Depreciation | $142M | $114M | $88M | $57M | $42M | $27M | |
| Other Non-current Assets | $120M | $82M | $83M | $95M | $97M | $13M | |
| Total Assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | |
| Accounts Payable | $507M | $432M | $273M | $298M | $235M | $138M | |
| Current Liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B | |
| Capital Leases | $52M | $61M | $67M | $72M | $77M | · | |
| Other Non-current Liabilities | $52M | $61M | $68M | $72M | $77M | $0 | |
| Total Liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | |
| Total Debt | $430M | $300M | $299M | · | $0 | · | |
| Common Stock | · | · | · | · | · | $2.0K | |
| Paid-in Capital | $4.26B | $3.87B | $3.68B | $3.51B | $3.39B | $133M | |
| Retained Earnings | $-3.29B | $-2.85B | $-2.88B | $-2.61B | $-2.00B | $-1.43B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | |
| AOCI | $18M | $-2M | $1M | $-10M | $-4M | $879.0K | |
| Stockholders' Equity | $978M | $1.01B | $804M | $890M | $1.39B | $-1.30B | |
| Liabilities + Equity | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
التدفق النقدي
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $29M | $32M | $31M | $15M | $15M | $11M | |
| Stock-based Comp | $88M | $110M | $160M | $112M | $86M | $36M | |
| Deferred Tax | $2M | $-2M | $58.0K | $-165.0K | $-101.0K | $-67.0K | |
| Other Non-cash | $1.42B | $813M | $-192M | · | $290M | · | |
| Operating Cash Flow | $1.09B | $978M | $-272M | $380M | $-182M | $223M | |
| CapEx | $36M | $28M | $26M | $29M | $26M | $14M | |
| Investing Cash Flow | $-241M | $-1.39B | $577M | $-227M | $-775M | $-345M | |
| Debt Issued | $410M | $0 | $0 | $305M | $0 | $147M | |
| Net Debt Issued | $410M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $399M | $68M | $6M | $301M | $1.24B | $612M | |
| Net Change in Cash | $1.25B | $-341M | $311M | $455M | $282M | $490M | |
| Taxes Paid | $18M | $674.0K | $2M | $2M | $697.0K | $2M | |
| Free Cash Flow | $1.06B | $950M | $-298M | · | $-208M | · | |
| Levered FCF | · | · | $-323M | · | $-212M | · |
الربحية
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.4% | 0.62% | -4.0% | · | -29.6% | · | |
| Net Margin | -3.8% | 0.28% | -4.6% | · | -31.1% | · | |
| Pretax Margin | -3.7% | 0.36% | -4.6% | · | -31.0% | · | |
| EBITDA Margin | -3.1% | 0.97% | -3.5% | · | -28.8% | · | |
| ROA | -7.9% | 0.60% | -6.7% | · | -20.5% | · | |
| ROE | -44.5% | 2.8% | -32.0% | · | -36.7% | · | |
| ROIC | -28.5% | 3.4% | -21.6% | · | -39.3% | · |
السيولة والملاءة
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | 1.3 | · | 1.2 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | · | 0.6 | · | |
| Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| LT Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| Interest Coverage | · | · | -9.6 | · | -115.4 | · |
الكفاءة
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.1 | 2.2 | 1.4 | · | 0.7 | · |
لكل سهم
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $44.60 | $34.52 | $26.45 | · | $10.27 | · | |
| Cash Flow / Share | $4.17 | $3.68 | $-1.23 | · | $-1.02 | · | |
| EPS (TTM) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | · |
معدلات النمو
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 27.5% | 56.5% | 47.9% | 115.6% | 297.3% | · | |
| Revenue CAGR 3Y | 43.5% | 70.9% | 133.1% | · | · | · | |
| Revenue CAGR 5Y | 90.8% | · | · | · | · | · |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | · | |
| Net Income TTM | $-443M | $25M | $-271M | $-606M | $-573M | · | |
| P/E | -8.5 | 134.4 | -7.5 | -0.9 | -2.5 | · | |
| Earnings Yield | -11.8% | 0.74% | -13.3% | -115.9% | -40.8% | · |
قائمة الدخل
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B | $1.52B | $1.47B | $995M | $978M | |
| SG&A Expense | $691M | $706M | $511M | $522M | $534M | $483M | $466M | $460M | $435M | $394M | $364M | $326M | $337M | $399M | $1.02B | $79M | |
| Operating Income | $389M | $704M | $-334M | $-129M | $-230M | $297M | $-148M | $-48M | $68M | $186M | $-145M | $-58M | $-7M | $-25M | $-222M | $-192M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | |
| Other Non-op | $-915.0K | $71.0K | $-20M | $-3M | $3M | $-3M | $68.0K | $2M | $-872.0K | $-1M | $1M | $-414.0K | $-2M | $-6M | $1M | $3M | |
| Pretax Income | $383M | $699M | $-353M | $-139M | $-234M | $288M | $-154M | $-52M | $61M | $178M | $-151M | $-65M | $-14M | $-38M | $-227M | $-195M | |
| Income Tax | $21M | $20M | $-247.0K | $-2M | $-5M | $13M | $-404.0K | $2M | $5M | $996.0K | $-806.0K | $915.0K | $1M | $2M | $-715.0K | $-2M | |
| Net Income | $362M | $679M | $-353M | $-137M | $-228M | $275M | $-154M | $-55M | $56M | $177M | $-150M | $-65M | $-16M | $-40M | $-226M | $-193M | |
| EPS (Basic) | $1.20 | $2.28 | $-1.37 | $-0.53 | $-0.89 | $1.10 | $-0.68 | $-0.22 | $0.24 | $0.77 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| EPS (Diluted) | $1.10 | $2.07 | $-1.19 | $-0.53 | $-0.89 | $0.92 | $-0.50 | $-0.22 | $0.20 | $0.62 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| Shares (Basic) | 302,220,000 | 298,184,000 | · | 259,273,000 | 255,531,000 | 251,279,000 | · | 243,106,000 | 238,672,000 | 231,443,000 | · | 223,099,000 | 219,400,000 | 216,913,000 | · | 212,822,733 | |
| Shares (Diluted) | 333,432,000 | 329,751,000 | · | 259,273,000 | 255,531,000 | 305,938,000 | · | 243,106,000 | 303,965,000 | 293,796,000 | · | 223,099,000 | 219,400,000 | 216,913,000 | · | 212,822,733 | |
| EBITDA | $389M | $711M | · | $-129M | $-230M | $304M | · | $-48M | $68M | $193M | · | $-58M | $-7M | $-20M | · | $-192M |
الميزانية العمومية
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B | $1.40B | $2.32B | $2.11B | $1.56B | $2.11B | |
| Receivables | $380M | $587M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $60M | $26M | $24M | $29M | $30M | $23M | $21M | $21M | $16M | $9M | · | $8M | $8M | $11M | · | $16M | |
| Current Assets | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B | $3.36B | $3.50B | · | $2.99B | $4.19B | $4.13B | · | $3.93B | |
| PP&E (Net) | $101M | $94M | $88M | $83M | $78M | $72M | $67M | $67M | $64M | $61M | · | $62M | $63M | $64M | · | $56M | |
| PP&E (Gross) | · | · | $230M | · | · | · | $181M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $142M | · | · | · | $114M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $122M | $123M | $120M | $121M | $116M | $94M | $82M | $84M | $87M | $87M | · | $89M | $92M | $95M | · | $97M | |
| Total Assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B | |
| Accounts Payable | $526M | $506M | $650M | $557M | $584M | $634M | $432M | $395M | $348M | $303M | · | $260M | $262M | $299M | · | $252M | |
| Current Liabilities | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B | $2.95B | $3.50B | $3.02B | · | $2.06B | $3.24B | $3.18B | · | $2.85B | |
| Capital Leases | · | · | $52M | · | · | · | $61M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $50M | $51M | $52M | $56M | $57M | $59M | $61M | $64M | $65M | $66M | · | $69M | $70M | $71M | · | $74M | |
| Total Liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | · | $2.43B | $3.61B | $3.55B | · | $3.22B | |
| Total Debt | $432M | $431M | · | $686M | $300M | $300M | · | $299M | $299M | $299M | · | $299M | $298M | $298M | · | $298M | |
| Paid-in Capital | $4.32B | $4.28B | $4.26B | $3.95B | $3.95B | $3.90B | $3.87B | $3.84B | $3.79B | $3.74B | · | $3.65B | $3.62B | $3.58B | · | $3.48B | |
| Retained Earnings | $-2.25B | $-2.62B | $-3.29B | $-2.94B | $-2.80B | $-2.58B | $-2.85B | $-2.70B | $-2.64B | $-2.70B | · | $-2.73B | $-2.66B | $-2.65B | · | $-2.38B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| AOCI | $-8M | $5M | $18M | $16M | $14M | $10M | $-2M | $26M | $-3M | $-3M | · | $-4M | $-7M | $-4M | · | $-14M | |
| Stockholders' Equity | $2.05B | $1.66B | $978M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | · | $919M | $950M | $930M | · | $1.08B | |
| Liabilities + Equity | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B |
التدفق النقدي
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $7M | $8M | $7M | $7M | $7M | $9M | $8M | $8M | $8M | $8M | $9M | $9M | $5M | $4M | $4M | |
| Stock-based Comp | $21M | $16M | $18M | $20M | $24M | $25M | $26M | $29M | $29M | $26M | $26M | $29M | $33M | $71M | $29M | $29M | |
| Deferred Tax | $-2M | $-6M | $3M | $-175.0K | $-36.0K | $36.0K | $-2M | $-119.0K | $130.0K | $-79.0K | $-37.0K | $69.0K | $209.0K | $-183.0K | $-171.0K | $2.0K | |
| Other Non-cash | · | $1.92B | · | · | · | $572M | · | · | · | $423M | · | · | · | $378M | · | · | |
| Operating Cash Flow | $2.09B | $2.62B | $672M | $-965M | $509M | $879M | $347M | $-500M | $497M | $634M | $297M | $-1.15B | $166M | $415M | $151M | $-548M | |
| CapEx | $12M | $9M | $9M | $9M | $9M | $9M | $7M | $8M | $8M | $6M | $6M | $6M | $6M | $7M | $7M | $10M | |
| Investing Cash Flow | $-2.83B | $-590M | $-49M | $150M | $-168M | $-174M | $-31M | $-578M | $-478M | $-301M | $172M | $225M | $44M | $136M | $-707M | $299M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $-4M | $8M | $364M | $22M | $5M | $4M | $19M | $19M | $27M | $1M | $2M | $3M | $506.0K | $527.0K | $423.0K | |
| Net Change in Cash | $-729M | $2.03B | $631M | $-451M | $363M | $709M | $319M | $-1.06B | $38M | $361M | $470M | $-922M | $212M | $551M | $-555M | $-249M | |
| Taxes Paid | $1M | $44.0K | $19.0K | $2M | $15M | $0 | $38.0K | $552.0K | · | · | $1M | $600.0K | · | · | $233.0K | $555.0K | |
| Free Cash Flow | · | $2.61B | · | · | · | $870M | · | · | · | $628M | · | · | · | $407M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $623M | · | · | · | $401M | · | · |
الربحية
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.0% | 15.2% | · | -4.3% | -8.1% | 9.8% | · | -2.0% | 3.1% | 8.7% | · | -4.0% | -0.43% | -1.7% | · | -19.7% | |
| Net Margin | 7.4% | 14.6% | · | -4.6% | -8.0% | 9.0% | · | -2.2% | 2.5% | 8.3% | · | -4.5% | -1.0% | -2.7% | · | -19.7% | |
| Pretax Margin | 7.8% | 15.0% | · | -4.7% | -8.2% | 9.5% | · | -2.2% | 2.8% | 8.3% | · | -4.5% | -0.94% | -2.6% | · | -20.0% | |
| EBITDA Margin | 8.0% | 15.3% | · | -4.3% | -8.1% | 10.0% | · | -2.0% | 3.1% | 9.0% | · | -4.0% | -0.43% | -1.4% | · | -19.7% | |
| ROA | 4.1% | 9.0% | · | -2.7% | -4.0% | 5.4% | · | -1.4% | 1.2% | 4.0% | · | -1.7% | -0.33% | -0.90% | · | -5.2% | |
| ROE | 22.5% | 45.3% | · | -12.6% | -19.9% | 23.3% | · | -5.2% | 5.4% | 18.1% | · | -6.5% | -1.4% | -3.5% | · | -14.6% | |
| ROIC | 14.8% | 32.7% | · | -7.5% | -15.5% | 17.4% | · | -3.4% | 4.4% | 13.9% | · | -4.9% | -0.57% | -2.2% | · | -13.8% |
السيولة والملاءة
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.0 | 1.2 | · | 1.5 | 1.3 | 1.3 | · | 1.4 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 31.4 | · | -9.5 | -1.1 | -4.1 | · | -31.4 |
الكفاءة
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 25.7 | 15.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
لكل سهم
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $14.64 | $14.09 | · | $11.52 | $11.21 | $9.96 | · | $9.97 | $7.30 | $7.29 | · | $6.45 | $6.93 | $6.78 | · | $4.60 | |
| Cash Flow / Share | · | $7.94 | · | · | · | $2.87 | · | · | · | $2.16 | · | · | · | $1.91 | · | · | |
| EPS (TTM) | $1.45 | $-0.54 | · | $-1.00 | $-0.69 | $0.40 | · | $-0.08 | $-0.15 | $-0.42 | · | $-1.59 | $-2.21 | $-2.67 | · | $-2.63 |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.32B | $13.30B | · | $11.29B | $10.73B | $10.08B | · | $8.22B | $7.23B | $6.54B | · | $5.43B | $4.96B | $4.46B | · | $3.46B | |
| Net Income TTM | $551M | $-39M | · | $-244M | $-161M | $123M | · | $29M | $18M | $-54M | · | $-347M | $-474M | $-571M | · | $-579M | |
| P/E | 19.7 | -21.2 | · | -18.9 | -31.1 | 32.8 | · | -265.1 | -105.5 | -35.4 | · | -3.5 | -3.6 | -2.4 | · | -1.9 | |
| Earnings Yield | 5.1% | -4.7% | · | -5.3% | -3.2% | 3.0% | · | -0.38% | -0.95% | -2.8% | · | -28.5% | -27.4% | -40.8% | · | -52.7% |
أحدث فترة على اليسار · القيم الفارغة معروضة كـ ·
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
| المقياس | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| الإيرادات | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| هامش الربح التشغيلي % | -3.4% | 0.62% | -4.0% | · | -29.6% |
| صافي الدخل | $-443M | $25M | $-271M | $-606M | $-573M |
| EPS المخفف | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
| المقياس | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.4 | 0.3 | 0.4 | · | 0.0 |
| النسبة الحالية | 0.9 | 0.8 | 1.3 | · | 1.2 |
| النسبة السريعة | 0.6 | 0.6 | 0.8 | · | 0.6 |
| المقياس | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $1.06B | $950M | $-298M | · | $-208M |
الملاك المؤسسيون (13F) 459 مقدمي إقرار · $6.2B إجمالي · حتى تاريخ 30 سبتمبر، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 125 (+51 مقابل الربع السابق) | 46 (-18 مقابل الربع السابق) | 147 (+22 مقابل الربع السابق) | 115 (+3 مقابل الربع السابق) | +22.8M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| BlackRock, Inc. | $587153449 | 20587428 | 9,50% | الأسهم |
| D. E. Shaw & Co., Inc. | $360595957 | 12643617 | 5,84% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $314559172 | 11029424 | 5,09% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $301725543 | 10579437 | 4,88% | الأسهم |
| VANGUARD GROUP INC | $297476962 | 20701250 | 4,82% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $258255502 | 9055242 | 4,18% | الأسهم |
| JANE STREET GROUP, LLC | $181530912 | 6365039 | 2,94% | الأسهم |
| Thrive Capital Management, LLC | $180919957 | 6343617 | 2,93% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $165994311 | 5819186 | 2,69% | الأسهم |
| STATE STREET CORP | $165454531 | 5801351 | 2,68% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $162917648 | 5712400 | 2,64% | عقد خيار الشراء |
| FMR LLC | $142557861 | 4998523 | 2,31% | الأسهم |
| CITADEL ADVISORS LLC | $120626823 | 4229552 | 1,95% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $115097850 | 4035689 | 1,86% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $101885043 | 3571731 | 1,65% | الأسهم |
| BIT Capital GmbH | $97480134 | 3417957 | 1,58% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $93673940 | 3284500 | 1,52% | الأسهم |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $86282012 | 3025316 | 1,40% | الأسهم |
| GLYNN CAPITAL MANAGEMENT LLC | $73462615 | 2575828 | 1,19% | الأسهم |
| CITADEL ADVISORS LLC | $72469320 | 2541000 | 1,17% | عقد خيار الشراء |
| GOLDMAN SACHS GROUP INC | $65298165 | 2289557 | 1,06% | الأسهم |
| NORTHERN TRUST CORP | $63063680 | 2211209 | 1,02% | الأسهم |
| WOLVERINE ASSET MANAGEMENT LLC | $61825656 | 2167800 | 1,00% | عقد خيار البيع |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60458493 | 2119863 | 0,98% | الأسهم |
| MORGAN STANLEY | $60299272 | 2114280 | 0,98% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55351616 | 1940800 | 0,90% | عقد خيار البيع |
| JANE STREET GROUP, LLC | $53968396 | 1892300 | 0,87% | عقد خيار الشراء |
| Nuveen, LLC | $50501648 | 1770745 | 0,82% | الأسهم |
| BlackBarn Capital Partners LP | $49910000 | 1750000 | 0,81% | عقد خيار البيع |
| BNP PARIBAS FINANCIAL MARKETS | $48660710 | 1706196 | 0,79% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $45996029 | 1612764 | 0,74% | الأسهم |
| CITADEL ADVISORS LLC | $44459828 | 1558900 | 0,72% | عقد خيار البيع |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $41354000 | 1450000 | 0,67% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $37594294 | 1318173 | 0,61% | الأسهم |
| Assenagon Asset Management S.A. | $35592732 | 1247992 | 0,58% | الأسهم |
| TWO SIGMA ADVISERS, LP | $35534136 | 2472800 | 0,58% | الأسهم |
| UBS Group AG | $34596357 | 1213056 | 0,56% | الأسهم |
| JANE STREET GROUP, LLC | $33796200 | 1185000 | 0,55% | عقد خيار البيع |
| GROUP ONE TRADING LLC | $32744154 | 1148112 | 0,53% | الأسهم |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $31200652 | 1093992 | 0,51% | الأسهم |
| Qube Research & Technologies Ltd | $30913940 | 1083939 | 0,50% | الأسهم |
| TUDOR INVESTMENT CORP ET AL | $29055948 | 1018792 | 0,47% | الأسهم |
| GILDER GAGNON HOWE & CO LLC | $28576515 | 1001982 | 0,46% | الأسهم |
| JPMORGAN CHASE & CO | $26387407 | 885558 | 0,43% | الأسهم |
| FEDERATED HERMES, INC. | $26096200 | 915014 | 0,42% | الأسهم |
| WELLS FARGO & COMPANY/MN | $23408907 | 820789 | 0,38% | الأسهم |
| Walleye Capital LLC | $23243058 | 814974 | 0,38% | الأسهم |
| Point72 Asset Management, L.P. | $22809212 | 799762 | 0,37% | الأسهم |
| Walleye Trading LLC | $22744700 | 797500 | 0,37% | عقد خيار الشراء |
| Bank of New York Mellon Corp | $22032138 | 772515 | 0,36% | الأسهم |
الناشطون والمالكون بنسبة 5%+ 2 حيازتان
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC | 18 سبتمبر، 2026 | 12,10% | تعديل | · | SEC |
| Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 إيداعات | 13 نوفمبر، 2024 | · | إيداع أولي | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
المطلعون على الشركة 23 من المطلعين · مسؤولون 12 · مديرون 12
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Mark T Bertolini | Chief Executive Officer | 30 يونيو، 2026 S | 7751570 | 1 | 8 | $-58759399 |
| Richard Scott Blackley | Chief Financial Officer | 3 سبتمبر، 2026 S | 1046108 | 0 | 9 | $-7941907 |
| Janet Liang | President, Oscar Insurance | 3 سبتمبر، 2026 S | 248697 | 0 | 5 | $-821072 |
| Steven Wolin | Chief Operating Officer | 1 ديسمبر، 2024 M | 102598 | 0 | 0 | $0 |
| Meghan V. Joyce | Chief Operating Officer | 1 مارس، 2022 M | 43070 | 0 | 0 | $0 |
| Joshua Kushner | Co-Founder and Vice Chairman | 18 سبتمبر، 2026 J | 0 | 0 | 0 | $0 |
| Victoria Baltrus | Chief Accounting Officer | 3 سبتمبر، 2026 S | 213631 | 0 | 5 | $-194480 |
| Adam Mcananey | Chief Legal Officer | 3 سبتمبر، 2026 S | 209004 | 0 | 5 | $-783513 |
| Alessandrea C. Quane | EVP, Chief Insurance Officer | 5 ديسمبر، 2024 M | 430216 | 0 | 0 | $0 |
| Ranmali Bopitiya | EVP & Chief Legal Officer | 1 ديسمبر، 2024 M | 241488 | 0 | 0 | $0 |
| Dennis Weaver | Chief Clinical Officer | 1 ديسمبر، 2022 M | 27110 | 0 | 0 | $0 |
| Joel Klein | Chief Policy & Strat. Officer | 18 أغسطس، 2021 M | 17 | 0 | 0 | $0 |
| Vanessa Ames Wittman | مدير | 18 سبتمبر، 2026 S | 112121 | 0 | 1 | $-806000 |
| Mario Schlosser | مدير | 3 سبتمبر، 2026 S | 449444 | 0 | 29 | $-68790950 |
| William Gassen | مدير | 9 يوليو، 2026 A | 82840 | 0 | 0 | $0 |
| David Plouffe | مدير | 9 يوليو، 2026 A | 137121 | 0 | 0 | $0 |
| Sid Sankaran | مدير | 9 يوليو، 2026 A | 22609 | 0 | 0 | $0 |
| Laura W Lang | مدير | 4 يونيو، 2026 A | 82840 | 0 | 0 | $0 |
| Jeffery H Boyd | مدير | 9 إبريل، 2026 A | 705673 | 0 | 0 | $0 |
| Elbert O. Robinson Jr. | مدير | 12 مايو، 2025 S | 64512 | 0 | 0 | $0 |
| Jr Charles E Phillips | مدير | 14 أكتوبر، 2022 A | 85787 | 0 | 0 | $0 |
| Teri List-Stoll | مدير | 5 مارس، 2021 A | 50000 | 0 | 0 | $0 |
| Ari Fischel | · | 5 مارس، 2021 A | 0 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 46 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| ABLS · Abacus FCF ETF Trust | 5,83% | 867 NS | 31 يوليو، 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,95% | 188213 SH | 2 أكتوبر، 2026 | يومي |
| RNIN · EA Series Trust | 1,20% | 70047 NS | 31 يوليو، 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,74% | 307696 NS | 31 يوليو، 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,60% | 69666 NS | 31 يوليو، 2026 | N-PORT |
| IWO · iShares Trust | 0,52% | 2269828 SH | 11 سبتمبر، 2026 | يومي |
| JSMD · Janus Detroit Street Trust | 0,51% | 171181 NS | 31 يوليو، 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,40% | 258034 SH | 19 أغسطس، 2026 | يومي |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 48469 SH | 2 أكتوبر، 2026 | يومي |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,35% | 152933 NS | 31 يوليو، 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,31% | 8798 NS | 31 يوليو، 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 61099 NS | 31 يوليو، 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,27% | 19102 NS | 31 يوليو، 2026 | N-PORT |
| IWM · iShares Trust | 0,26% | 6175602 SH | 11 سبتمبر، 2026 | يومي |
| FBUF · Fidelity Greenwood Street Trust | 0,25% | 1889 NS | 31 يوليو، 2026 | N-PORT |
| ISCG · iShares Trust | 0,24% | 71367 SH | 11 سبتمبر، 2026 | يومي |
| RSSL · Global X Funds | 0,24% | 115406 NS | 31 يوليو، 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,21% | 1387125 SH | 19 أغسطس، 2026 | يومي |
| FHEQ · Fidelity Greenwood Street Trust | 0,21% | 61010 NS | 31 يوليو، 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,19% | 3171535 SH | 19 أغسطس، 2026 | يومي |
| DFAS · Dimensional ETF Trust | 0,16% | 805292 NS | 31 يوليو، 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,16% | 145781 SH | 2 أكتوبر، 2026 | يومي |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 27872 NS | 31 يوليو، 2026 | N-PORT |
| ESML · iShares Trust | 0,11% | 96895 SH | 11 سبتمبر، 2026 | يومي |
| FNCL · FIDELITY COVINGTON TRUST | 0,08% | 61975 NS | 31 يوليو، 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,08% | 5488922 SH | 19 أغسطس، 2026 | يومي |
| VFH · VANGUARD WORLD FUND | 0,08% | 384466 SH | 19 أغسطس، 2026 | يومي |
| WSML · iShares Trust | 0,07% | 14630 SH | 11 سبتمبر، 2026 | يومي |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 2534194 SH | 19 أغسطس، 2026 | يومي |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 12495 SH | 2 أكتوبر، 2026 | يومي |
| DFSU · Dimensional ETF Trust | 0,03% | 20892 NS | 31 يوليو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 21472 NS | 31 يوليو، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 286808 NS | 31 يوليو، 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 12166 NS | 31 يوليو، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 50403 NS | 31 يوليو، 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 64590 SH | 11 سبتمبر، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 7601113 SH | 19 أغسطس، 2026 | يومي |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 194738 SH | 19 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19808 SH | 19 أغسطس، 2026 | يومي |
| DFUS · Dimensional ETF Trust | 0,01% | 66708 NS | 31 يوليو، 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 53203 SH | 19 أغسطس، 2026 | يومي |
| ITOT · iShares Trust | 0,01% | 287602 SH | 11 سبتمبر، 2026 | يومي |
| DXUV · Dimensional ETF Trust | 0,00% | 472 NS | 31 يوليو، 2026 | N-PORT |
| IAK · iShares Trust | · | 117671 SH | 11 سبتمبر، 2026 | يومي |
| ISCB · iShares Trust | · | 10063 SH | 11 سبتمبر، 2026 | يومي |
| SMLF · iShares Trust | · | 286871 SH | 11 سبتمبر، 2026 | يومي |
OSCR توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
السعر المستهدف لمدة 12 شهرًا
10 محللين · 2026-10-03السعر المستهدف المتوسط $35.40 +14,4%
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
أساس السنة المالية، الأسعار كما في إغلاق نهاية السنة المالية الأخيرة لكل شركة.
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| OSCR | · | -8.5 | 27.5% | -3.8% | -44.5% | · |
| AFL | $57.20B | 16.2 | -9.3% | 21.2% | 12.9% | · |
| PRU | · | · | · | · | · | · |
| PFG | $19.18B | 16.8 | -3.1% | 7.6% | 10.3% | · |
| UNM | · | · | · | · | · | · |
| GL | $12.90B | 9.9 | 3.7% | 19.4% | 20.4% | · |
| PRI | $8.22B | 11.3 | 6.6% | 22.8% | 31.9% | · |
| LNC | $8.46B | 7.6 | -1.2% | 6.5% | 12.3% | · |
| CNO | $4.01B | 18.5 | 0.85% | 5.1% | 8.9% | · |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة + بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.